The Marshall A. Lichtman Specialized Center of Research (SCOR) program was established to encourage multidisciplinary research focused on the prevention, diagnosis, or treatment of leukemia, lymphoma or myeloma. The program requires synergy among at least three research programs and these programs may be supported by scientific core laboratories. The program permits an application for a competitive renewal of the SCOR grant after five years depending on the progress shown. The program is organized to encourage the interaction of complementary sciences and the linkage of basic sciences to a translational research program.

The center's maximal annual total cost, direct and indirect, cannot exceed $1.25 million. The aggregate costs over five years cannot exceed $6.25 million. The direct costs, if justified by the aggregate budget may be up to $1.042 million per year. The indirect or institutional costs cannot exceed 20 percent of the direct costs per year.

Application Process

A Letter of Intent is due each year via proposalcentral by Nov. 1.  Unlike The Leukemia & Lymphoma Society's (LLS) other research programs, SCOR applicants must be invited to submit a full application (after completing a LOI).  The invitation to submit a full proposal will be announced by Dec. 31.  The full application must be submitted by March 15.

Important: Revised Policies and Procedures as of 2008

Please read: Guidelines & Instructions

This program is closed for 2010 submission and will open again in July for 2011 applications.

LLS is using proposalCentral for the 2011 SCOR application submission.  Investigators and grants officials will be required to register before applying via https://proposalcentral.altum.com/. 

2008 SCOR Subcommittee Members

For more program information contact:
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605
Telephone: (914) 821-8301/ 8290, or
Email: researchprograms@lls.org